Campbell & CO Investment Adviser LLC Moderna, Inc. Transaction History

Campbell & CO Investment Adviser LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $225,820 - $368,510	-1,000 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $66,570 - $145,341	-300 Reduced 23.08%	1,000 $385,000
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $168,883 - $305,474	1,300 New	1,300 $305,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.